Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2017 December;63(4) > Minerva Gastroenterologica e Dietologica 2017 December;63(4):337-44

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

Rivista di Gastroenterologia, Nutrizione e Dietetica


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEW  GUT MICROBIOTA AND GASTROINTESTINAL TRACT, LIVER AND PANCREAS: FROM PHYSIOLOGY TO PATHOLOGY


Minerva Gastroenterologica e Dietologica 2017 December;63(4):337-44

DOI: 10.23736/S1121-421X.17.02376-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Gut microbiota, obesity and metabolic disorders

Alessandro FEDERICO 1 , Marcello DALLIO 1, Rosa DI SARNO 1, Valentina GIORGIO 2, Luca MIELE 3

1 Department of Clinical and Experimental Medicine, University of Campania “L. Vanvitelli”, Naples, Italy; 2 Department of Pediatrics, Fondazione Policlinico Gemelli, Sacro Cuore Catholic University, Rome, Italy; 3 Internal Medicine, Gastroenterology and Liver Unit, A. Gemelli Polyclinic, Sacro Cuore Catholic University, Rome, Italy


PDF  


Obesity, diabetes and metabolic disorders represent hugely significant problems concerning the health in Western countries and the study of gut microbiota in metabolic pathologies is part of this framework. Diet effects on intestinal microbial composition and its role in pathogenetic mechanisms responsible for both obesity and systemic, hepatic and adipose tissue inflammation, represent at the moment one of this mostpromising topic in gastroenterology research. Gut health safety is essential, but it needs to be further explored in order to understand and interrupt the pathogenetic mechanisms, which support a large number of diseases. The aim of this review is to describe what are the modifications of gut microbial composition that occur in metabolic disorders and the role of gut microbiota in the pathogenesis of several diseases such as obesity, metabolic syndrome and type II diabetes mellitus, showing how gut microbiota and adipose tissue, liver and brain, together with intestinal permeability increase, carry out an interconnection systemthat plays a pivotal role in the field.


KEY WORDS: Obesity - Gastrointestinal microbiome - Non-alcoholic fatty liver disease - Metabolic syndrome X

inizio pagina

Publication History

Issue published online: September 18, 2017

Per citare questo articolo

Federico A, Dallio M, Di Sarno R, Giorgio V, Miele L. Gut microbiota, obesity and metabolic disorders. Minerva Gastroenterol Dietol 2017;63:337-44. DOI: 10.23736/S1121-421X.17.02376-5

Corresponding author e-mail

alessandro.federico@unina2.it